Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.900 | 0.964 | 28 | 2007 | 2019 | |||||
Obesity
|
1111 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.900 | 1.000 | 15 | 2007 | 2019 | |||||
Body mass index
|
2689 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.800 | 1.000 | 5 | 2009 | 2019 | |||||
Body mass index procedure
|
252 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.700 | 1.000 | 3 | 2009 | 2013 | |||||
Diabetes
|
710 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.030 | 1.000 | 3 | 2010 | 2016 | |||||
Diabetes Mellitus
|
824 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.030 | 1.000 | 3 | 2010 | 2016 | |||||
Finding of body mass index
|
252 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.700 | 1.000 | 3 | 2009 | 2013 | |||||
Gestational Diabetes
|
224 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.030 | 1.000 | 3 | 2012 | 2018 | |||||
Polycystic Ovary Syndrome
|
363 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.030 | 1.000 | 3 | 2015 | 2018 | |||||
Adenoma
|
103 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Adenoma of large intestine
|
213 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
adiposity
|
10 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Age at menarche
|
591 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||
Alcoholic Intoxication, Chronic
|
441 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Attention deficit hyperactivity disorder
|
420 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Blood urea nitrogen measurement
|
174 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Body Weight
|
92 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.800 | 1.000 | 1 | 2009 | 2009 | |||||
Chronic Obstructive Airway Disease
|
852 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Coronary heart disease
|
1178 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Fatty Liver Disease
|
81 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Latent autoimmune diabetes mellitus in adult
|
12 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant Neoplasms
|
1641 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Metabolic Syndrome X
|
591 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Neural Tube Defects
|
122 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Physical Activity Measurement
|
355 | 0.716 | 0.560 | 16 | 53782363 | intron variant | C/A | snv | 0.40 | 0.700 | 1.000 | 1 | 2017 | 2017 |